These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20156651)

  • 41. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
    Gillberg PG; Sundquist S; Nilvebrant L
    Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.
    Mansfield KJ; Liu L; Moore KH; Vaux KJ; Millard RJ; Burcher E
    BJU Int; 2007 Jun; 99(6):1433-8. PubMed ID: 17428242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity.
    Kullmann FA; Artim DE; Birder LA; de Groat WC
    J Neurosci; 2008 Feb; 28(8):1977-87. PubMed ID: 18287514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The subtypes of muscarinic receptors for neurogenic bladder contraction in rats.
    Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Nishikibe M; Noguchi K
    Eur J Pharmacol; 2002 Oct; 452(2):245-53. PubMed ID: 12354576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3 toward M2.
    Braverman AS; Ruggieri MR
    Am J Physiol Regul Integr Comp Physiol; 2003 Sep; 285(3):R701-8. PubMed ID: 12763741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat.
    Tong YC; Cheng JT
    J Urol; 2007 Oct; 178(4 Pt 1):1537-42. PubMed ID: 17707055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postjunctional modulation by muscarinic M2 receptors of responses to electrical field stimulation of rat detrusor muscle preparations.
    Giglio D; Delbro DS; Tobin G
    Auton Autacoid Pharmacol; 2005 Jul; 25(3):113-20. PubMed ID: 15955031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractions.
    Braverman AS; Tallarida RJ; Ruggieri MR
    J Pharmacol Exp Ther; 2008 Jun; 325(3):954-60. PubMed ID: 18339971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential coupling of muscarinic M1, M2, and M3 receptors to phosphoinositide hydrolysis in urinary bladder and longitudinal muscle of the ileum of the mouse.
    Tran JA; Matsui M; Ehlert FJ
    J Pharmacol Exp Ther; 2006 Aug; 318(2):649-56. PubMed ID: 16675640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors.
    Fisher JT; Vincent SG; Gomeza J; Yamada M; Wess J
    FASEB J; 2004 Apr; 18(6):711-3. PubMed ID: 14977875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder.
    Mizutani H; Sakakibara F; Sasaki E
    J Pharmacol Exp Ther; 2020 Jul; 374(1):84-92. PubMed ID: 32332112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.
    Abrams P; Andersson KE; Buccafusco JJ; Chapple C; de Groat WC; Fryer AD; Kay G; Laties A; Nathanson NM; Pasricha PJ; Wein AJ
    Br J Pharmacol; 2006 Jul; 148(5):565-78. PubMed ID: 16751797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of cholinesterase inhibition in supraspinal and spinal neural pathways on the micturition reflex in rats.
    Masuda H; Chancellor MB; Kihara K; Sakai Y; Koga F; Azuma H; de Groat WC; Yoshimura N
    BJU Int; 2009 Oct; 104(8):1163-9. PubMed ID: 19338542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
    Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ
    J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. II. Denervated rat bladder.
    Braverman AS; Doumanian LR; Ruggieri MR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):875-80. PubMed ID: 16243962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muscarinic receptors in the bladder: from basic research to therapeutics.
    Hegde SS
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat.
    Aizawa N; Ito H; Sugiyama R; Fujimura T; Suzuki M; Fukuhara H; Homma Y; Igawa Y
    J Urol; 2015 Apr; 193(4):1423-32. PubMed ID: 25219701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M
    Hara H; Imamura T; Suzuki A; Ueno M; Minagawa T; Ogawa T; Ishizuka O
    Low Urin Tract Symptoms; 2023 Mar; 15(2):68-75. PubMed ID: 36543093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
    McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
    Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The M2 muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder.
    Ehlert FJ; Griffin MT; Abe DM; Vo TH; Taketo MM; Manabe T; Matsui M
    J Pharmacol Exp Ther; 2005 Apr; 313(1):368-78. PubMed ID: 15608083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.